Introduction {#sec0005}
============

*Gordonia* (formerly; *Gordona*), a bacteria species with taxonomic classification under the sub-order of *Corynebacterium* under *Actinomycetales* \[[@bib0005]\]. They are aerobic, gram-positive and weakly acid-fast *Coccobacilli* that are frequently mistaken as *Rhodococcus* or *Nocardia* bacteria by conventional identification methods \[[@bib0010],[@bib0015]\]. Given the organism's ability to biodegrade \[[@bib0020]\] and adhere to rubber with biofilms formation, its pathogenicity was linked to long-term indwelling catheters and implantable devices \[[@bib0010],[@bib0020],[@bib0025]\]. However, possible infections unrelated to medical devices include wound and skin infections, mediastinitis, otitis externa, brain or breast abscesses, arthritis and ocular infections were reported as well \[[@bib0010],[@bib0020],[@bib0030]\].

Case report {#sec0010}
===========

A 50-year-old male presented to our center with a one-month history of progressive right-sided weakness and urinary incontinence. He also reported intermittent neck and right-sided body pain, fever and night sweats. He unintentionally lost around 18 lbs. in weight. Systemic review was unremarkable, particularly for headaches, vomiting, dysphasia, dysphagia, altered sensorium, seizures, cognitive impairment and change in vision. On clinical examination he was found to be emaciated and depressed. No signs of instability, pallor, jaundice, palpable lymph nodes or meningism were identified but oral thrush was noted. Examination of cardiovascular system, chest, and abdomen revealed no abnormality. Neurological examination revealed diffuse muscle wasting, global hypertonia and hyperreflexia as well as significantly reduced power on the right side. Sensation was diminished on the right side of body. Initial blood investigations including basic hemo-gram and biochemical profile were unremarkable except for mild relative lymphopenia.

Magnetic Resonance Imaging (MRI) of the brain showed multiple, bilateral and asymmetrical ring enhancing (T1 hypo-intense, T2 and FLAIR hyper-intense) lesions of varying sizes in cerebral hemispheres, right basal ganglia and cerebellum with perilesional edema. The largest lesion was located on right frontal lobe and measured 30 × 24 mm, surrounded by vasogenic edema and causing mass effects ([Fig. 1](#fig0005){ref-type="fig"}: A). HIV tests panel reported as following: positive antibodies screening test; viral load = 317,077 RNA copies/mL; helper cells (CD4) Count 7/μL, CD4:CD8 ratio = 0.03. Screening for *Cryptococcus* and TORCH (*Toxoplasmosis, Rubella, Cytomegalovirus and Herpes*) was negative. Lumbar puncture is thought to be unsafe in view of increased intra-cranial pressure.Fig. 1MRI Brain: showing ring enhancing lesions before (A) and after (B) the treatment.Fig. 1

The patient underwent diagnostic brain biopsy. No organism was seen on gram, India ink and acid-fast stains. 24 h later, some whitish dry non-hemolytic colonies were observed on 5% sheep blood agar and chocolate plates. Gram staining of the colonies revealed medium to long beaded, non branching gram-positive rods, which were positive for modified acid-fast stain as well. At this stage and considering the clinical presentation, suspicion of *Nocardia* or other aerobic *Actinomyces* was raised. However, 48 h later, the growth looked slightly pinkish with undulating margins. Using API® Coryne strip (BioMérieux SA, Marcy l\'Etoile, France), the isolate was identified biochemically as *Rhodococcus* species. However, as this was inconsistent with morphological observations, we performed 16S rRNA gene sequencing which matched that of *Gordonia sputi*. The E-test minimum inhibitory concentration (MIC) was reported as following (in μg/mL): vancomycin 1.5; ceftrixone 1.5; imipenem 0.023; amikacin 0.19; gentamycin 0.032; meropenem 0.19; ciprofloxacin 0.125.

The patient was empirically begun on meropenem, vancomycin and rifampicin at admission to hospital. In light of antibacterials sensitivity tests, consensus opinion was to continue on this regimen for extended period of at least 4--6 weeks. Anti-retroviral (efavirenz, emtricitabine and tenofovir) treatment was started 2 weeks later. Repeated MRI after a month of treatment showed interval resolution of most of the lesions with remaining few lesions in the upper cerebrum with development of right frontal subdural hematoma adjacent to the previously noted large lesion and post-biopsy related changes ([Fig. 1](#fig0005){ref-type="fig"}: B).

The patient showed slow but apparent clinical improvement and remained clinically stable and afebrile. Unfortunately, after a month of hospitalization he developed progressive shortness of breath, hypoxemia and hypotension and was shifted to ICU with hospital acquired pneumonia. Chest radiograph showed bilateral infiltrates. *Acinetobacter* sensitive to colistin was isolated from sputum. Accordingly, colistin was added as well as trial of corticosteroids for possibility of Immune Reconstitution Inflammatory Syndrome (IRIS). Patient continued to deteriorate despite all supportive measures and, unfortunately, died few days after admission to ICU.

Discussion {#sec0015}
==========

The genus Gordonia was first described in 1971 by Tsukamura \[[@bib0035]\]. Fang et al. described twenty-nine *Gordonia* species \[[@bib0040]\]. Fortunately, only few can cause human infections, these include *Gordonia terrae*, *Gordonia sputi* and *Gordonia bronchialis*. Less frequently reported species are *Gordonia rubpropertincta, Gordonia polyisoprenivorans, Gordonia otitidis and Gordonia arenii*. *Gordonia* species may have multisystem involvement and typically affect immunocompromised hosts \[[@bib0030]\]. Seventeen cases of *Gordonia sputi* infection reported between 1996 and 2017 worldwide. Brust et al. has described *Gordonia sputi* septicemia in a patient with AIDS \[[@bib0025]\]. *Gordonia*-related CNS infections were reported In patients with no HIV infection, including meningitis and brain abscesses \[[@bib0045]\]. Differential diagnoses of brain ring-enhancing lesions in patients with HIV/AIDS are toxoplasmosis, cryptococcosis, lymphoma and tuberculoma. *Gordonia sputi* is a rare another cause, but should be suspected whenever common organisms are not identified.

Our patient responded to combined antibacterials regimen with noticeable clinical response. We believe that the cause of death was respiratory failure due to multi-drug resistant *Actinobacter* pneumonia. Choosing appropriate antibacterials is crucial in treatment of *Gordonia sputi* infection in immunocompromised patients. Blaschke et al. \[[@bib0050]\] elaborated on antibacterials sensitivity in a case series including 6 patients as well as another 24 cases previously published. They suggested the use of carbapenem or fluroquinolone in combination with aminoglycosides as empirical therapy for period of at least 4--6 weeks as relapses were reported with shorter period of treatment \[[@bib0050]\].

Conclusion {#sec0020}
==========

To our knowledge, this is the first report of *Gordonia sputi* related multiple brain abscesses as AIDS-presenting illness. Treatment of *Gordonia sputi* in setting of HIV infection with a combination of sensitivity-based antibacterials over a period of 4--6 weeks appears to be safe and effective.
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